{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:57:19Z","timestamp":1759564639825,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ejogrb.2014.02.042","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T00:45:57Z","timestamp":1394757957000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Leukotriene receptor antagonist as a novel tocolytic in an in vitro model of human uterine contractility"],"prefix":"10.1016","volume":"177","author":[{"given":"St\u00e9phanie","family":"Corriveau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Blouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2014.02.042_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jama.2012.153817","article-title":"Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial","volume":"309","author":"Roos","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0015","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1301\/nr.2007.dec.S194-S202","article-title":"Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury","volume":"65","author":"Romero","year":"2007","journal-title":"Nutr Rev"},{"issue":"420","key":"10.1016\/j.ejogrb.2014.02.042_bib0020","first-page":"e1","article-title":"Why eicosanoids could represent a new class of tocolytics on uterine activity in pregnant women","volume":"201","author":"Corriveau","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/07853899809005850","article-title":"The role of prostaglandins in human parturition","volume":"30","author":"Gibb","year":"1998","journal-title":"Ann Med"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1521-6934(03)00069-5","article-title":"The role of prostaglandins in the initiation of parturition","volume":"17","author":"Olson","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9378(95)90163-9","article-title":"Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study","volume":"173","author":"Rasanen","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0040","first-page":"1039","article-title":"ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologist. Number 43, May 2003. Management of preterm labor","volume":"101","author":"ACOG Committee on Practice Bulletins. American College of Obstetricians and Gynecologist","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(98)09019-9","article-title":"Leukotriene-receptor antagonists","volume":"353","author":"Lipworth","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0050","first-page":"849","article-title":"Increased concentrations of arachidonic acid lipoxygenase metabolites in amniotic fluid during parturition","volume":"70","author":"Romero","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1749-6632.1991.tb37879.x","article-title":"Evidence for 5-hydroxyeicosatetraenoic acid (5-HETE) and leukotriene C4(LTC4) in the onset of labor","volume":"622","author":"Walsh","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ab.2007.03.001","article-title":"Quantitative profiling of epoxyeicosatrienoic, hydroxyeicosatetraenoic, and dihydroxyeicosatetraenoic acids in human intrauterine tissues using liquid chromatography\/electrospray ionization tandem mass spectrometry","volume":"365","author":"Zhang","year":"2007","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0090-6980(82)90150-2","article-title":"Contraction of guinea pig uterus by synthetic leukotrienes","volume":"24","author":"Weichman","year":"1982","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0070","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0090-6980(85)90164-9","article-title":"Leukotrienes and myometrial activity of the term pregnant uterus","volume":"30","author":"Bryman","year":"1985","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0075","first-page":"79","article-title":"Effect of cysteinyl leukotrienes on uterine strips from pregnant and non-pregnant swine","volume":"29","author":"Ledwozyw","year":"1989","journal-title":"Pol Arch Weter"},{"issue":"266","key":"10.1016\/j.ejogrb.2014.02.042_bib0080","first-page":"e1","article-title":"Lipoxygenase and cyclooxygenase inhibitors reveal a complementary role of arachidonic acid derivatives in pregnant human myometrium","volume":"203","author":"Corriveau","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0085","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jaci.2006.12.618","article-title":"Safety of leukotriene receptor antagonists in pregnancy","volume":"119","author":"Bakhireva","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0090","first-page":"881","article-title":"Safety of using montelukast during pregnancy","volume":"56","author":"Koren","year":"2010","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0095","doi-asserted-by":"crossref","first-page":"L130","DOI":"10.1152\/ajplung.90436.2008","article-title":"Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung","volume":"296","author":"Morin","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","article-title":"Characterization of the human cysteinyl leukotriene CysLT1 receptor","volume":"399","author":"Lynch","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1734-1140(10)70306-6","article-title":"Transcellular biosynthesis of eicosanoids","volume":"62","author":"Sala","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1095\/biolreprod.106.051987","article-title":"Regional expression of prostaglandin E2 and F2alpha receptors in human myometrium, amnion, and choriodecidua with advancing gestation and labor","volume":"75","author":"Grigsby","year":"2006","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0115","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1071\/RD09148","article-title":"Expression and regulation of prostaglandin receptors in the human placenta and fetal membranes at term and preterm","volume":"22","author":"Unlugedik","year":"2010","journal-title":"Reprod Fertil Dev"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0120","first-page":"982","article-title":"Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor","volume":"78","author":"Sangha","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0125","doi-asserted-by":"crossref","first-page":"e34707","DOI":"10.1371\/journal.pone.0034707","article-title":"Nuclear factor kappa B activation occurs in the amnion prior to labour onset and modulates the expression of numerous labour associated genes","volume":"7","author":"Lim","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0130","first-page":"593","article-title":"Characterization of choriodecidual space as an effector molecule-rich environment that induces rupture of fetal membranes during labor","volume":"72","author":"Vega Sanchez","year":"2004","journal-title":"Ginecol Obstet Mex"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0135","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1471-0528.2003.02443.x","article-title":"The in vitro effect of dual combinations of ritodrine, nicardipine and atosiban on contractility of pregnant rat myometrium","volume":"110","author":"Doret","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0140","first-page":"267","article-title":"Side-effect and vital sign profile of nifedipine as a tocolytic for preterm labour","volume":"14","author":"Chan","year":"2008","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0150","doi-asserted-by":"crossref","first-page":"S1505","DOI":"10.1093\/ajcn\/83.6.1505S","article-title":"n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases","volume":"83","author":"Calder","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0155","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/0002-9149(83)90328-4","article-title":"Coronary constriction by leukotriene C4, D4, and E4 in the intact pig heart","volume":"51","author":"Ezra","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.prostaglandins.2006.05.012","article-title":"Effects of 5-oxo-ETE and 14,15-EET on reactivity and Ca2+ sensitivity in guinea pig bronchi","volume":"82","author":"Morin","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.ejogrb.2014.02.042_bib0165","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000312669","article-title":"Cysteinyl leukotrienes and their receptors: molecular and functional characteristics","volume":"85","author":"Singh","year":"2010","journal-title":"Pharmacology"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514001146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514001146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:31:34Z","timestamp":1759555894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211514001146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":32,"alternative-id":["S0301211514001146"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.02.042","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leukotriene receptor antagonist as a novel tocolytic in an in vitro model of human uterine contractility","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}